Browse by UCL people
Group by: Type | Date
Jump to: Article
Number of items: 31.
Article
Alberts, R;
de Vries, EMG;
Goode, EC;
Jiang, X;
Sampaziotis, F;
Rombouts, K;
Böttcher, K;
... Weersma, RK; + view all
(2018)
Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis.
Gut
, 67
(8)
pp. 1517-1524.
10.1136/gutjnl-2016-313598.
|
Aravinthan, AD;
Alexander, GJ;
(2018)
Telomere, telomerase and liver disease.
Liver International
, 38
(1)
pp. 33-34.
10.1111/liv.13630.
|
Arayinthan, AD;
Alexander, GJM;
(2016)
Senescence in chronic liver disease: Is the future in aging?
[Review].
Journal of Hepatology
, 65
(4)
pp. 825-834.
10.1016/j.jhep.2016.05.030.
|
Beebeejaun, K;
Amin-Chowdhury, Z;
Letley, L;
Kara, E;
Mahange, B;
Harrington, K;
Checkley, J;
... Edelstein, M; + view all
(2020)
Impact of a nurse‐led enhanced monitoring, management and contact tracing intervention for chronic hepatitis B in England, 2015‐2017.
Journal of Viral Hepatitis
10.1111/jvh.13403.
(In press).
|
Burton, A;
Tataru, D;
Driver, RJ;
Bird, TG;
Huws, D;
Wallace, D;
Cross, TJS;
... HCC-UK/BASL/NCRAS Partnership Steering Group, .; + view all
(2021)
Primary liver cancer in the UK: Incidence, incidence-based mortality, and survival by subtype, sex, and nation.
JHEP Reports
, 3
(2)
, Article 100232. 10.1016/j.jhepr.2021.100232.
|
Chapman, MH;
Thorburn, D;
Hirschfield, GM;
Webster, GGJ;
Rushbrook, SM;
Alexander, G;
Collier, J;
... Pereira, SP; + view all
(2019)
British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis.
Gut
10.1136/gutjnl-2018-317993.
(In press).
|
Cordell, HJ;
Han, Y;
Mells, GF;
Li, Y;
Hirschfield, GM;
Greene, CS;
Xie, G;
... Siminovitch, KA; + view all
(2015)
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways.
Nature Communications
, 6
, Article 8019. 10.1038/ncomms9019.
|
Darlay, R;
Ayers, KL;
Mells, GF;
Hall, LS;
Liu, JZ;
Almarri, MA;
Alexander, GJ;
... Cordell, HJ; + view all
(2018)
Amino acid residues in five separate HLA genes can explain most of the known associations between the MHC and primary biliary cholangitis.
PLoS Genetics
, 14
(12)
, Article e1007833. 10.1371/journal.pgen.1007833.
|
Demetris, AJ;
Bellamy, C;
Hübscher, SG;
O'Leary, J;
Randhawa, PS;
Feng, S;
Neil, D;
... Zen, Y; + view all
(2016)
2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection.
American Journal of Transplantation
, 16
(10)
pp. 2816-2835.
10.1111/ajt.13909.
|
Dyson, JK;
Wilkinson, N;
Jopson, L;
Mells, G;
Bathgate, A;
Heneghan, MA;
Neuberger, J;
... Jones, DEJ; + view all
(2016)
The inter-relationship of symptom severity and quality of life in 2055 patients with primary biliary cholangitis.
Alimentary Pharmacology and Therapeutics
, 44
(10)
pp. 1039-1050.
10.1111/apt.13794.
|
Grover, VPB;
Southern, L;
Dyson, JK;
Kim, JU;
Crossey, MME;
Wylezinska-Arridge, M;
Patel, N;
... Taylor-Robinson, SD; + view all
(2016)
Early primary biliary cholangitis is characterised by brain abnormalities on cerebral magnetic resonance imaging.
Alimentary Pharmacology & Therapeutics
, 44
(9)
pp. 936-945.
10.1111/apt.13797.
|
Hegade, VS;
Kendrick, SFW;
Dobbins, RL;
Miller, SR;
Richards, D;
Storey, J;
Dukes, G;
... Jones, DEJ; + view all
(2016)
BAT117213: Ileal bile acid transporter (IBAT) inhibition as a treatment for pruritus in primary biliary cirrhosis: study protocol for a randomised controlled trial.
BMC Gastroenterology
, 16
, Article 71. 10.1186/s12876-016-0481-9.
|
Hirschfield, GM;
Dyson, JK;
Alexander, GJM;
Chapman, MH;
Collier, J;
Hübscher, S;
Patanwala, I;
... Jones, DEJ; + view all
(2018)
The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines.
Gut
, 67
(9)
10.1136/gutjnl-2017-315259.
|
Huang, H;
Duggal, P;
Thio, CL;
Latanich, R;
Goedert, JJ;
Mangia, A;
Cox, AL;
... Kim, AY; + view all
(2017)
Fine-mapping of genetic loci driving spontaneous clearance of hepatitis C virus infection.
Scientific Reports
, 7
, Article 15843. 10.1038/s41598-017-16011-2.
|
Ji, S-G;
Juran, BD;
Mucha, S;
Folseraas, T;
Jostins, L;
Melum, E;
Kumasaka, N;
... Anderson, CA; + view all
(2017)
Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease.
Nature Genetics
, 49
pp. 269-273.
10.1038/ng.3745.
|
Liu, JZ;
Almarri, MA;
Gaffney, DJ;
Jostins, L;
Barrett, JC;
Anderson, CA;
Mells, GF;
... Davies, MH; + view all
(2012)
Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis.
Nature Genetics
, 44
(10)
1137 - 1141.
10.1038/ng.2395.
|
Owen, NE;
Alexander, GJ;
Sen, S;
Bunclark, K;
Polwarth, G;
Pepke-Zaba, J;
Davenport, AP;
... Upton, PD; + view all
(2020)
Reduced circulating BMP10 and BMP9 and elevated endoglin are associated with disease severity, decompensation and pulmonary vascular syndromes in patients with cirrhosis.
EBioMedicine
, 56
, Article 102794. 10.1016/j.ebiom.2020.102794.
|
Owen, NE;
Nyimanu, D;
Kuc, RE;
Upton, PD;
Morrell, NW;
Alexander, GJ;
Maguire, JJ;
(2021)
Plasma levels of apelin are reduced in patients with liver fibrosis and cirrhosis but are not correlated with circulating levels of bone morphogenetic protein 9 and 10.
Peptides
, 136
, Article 170440. 10.1016/j.peptides.2020.170440.
|
Potts, JR;
Farahi, N;
Howard, MR;
Taylor, MR;
Heard, S;
Shankar, AN;
Alexander, GJ;
... Peters, AM; + view all
(2018)
In vivo imaging of hepatic neutrophil migration in severe alcoholic hepatitis with ¹¹¹In-radiolabelled leucocytes.
Bioscience Reports
, 38
(4)
, Article BSR20180466. 10.1042/BSR20180466.
|
Sampaziotis, F;
Justin, AW;
Tysoe, OC;
Sawiak, S;
Godfrey, EM;
Upponi, SS;
Gieseck, RL;
... Vallier, L; + view all
(2017)
Reconstruction of the mouse extrahepatic biliary tree using primary human extrahepatic cholangiocyte organoids.
Nature Medicine
, 23
(8)
pp. 954-963.
10.1038/nm.4360.
|
Shribman, S;
Marjot, T;
Sharif, A;
Vimalesvaran, S;
Ala, A;
Alexander, G;
Dhawan, A;
... Bandmann, O; + view all
(2022)
Investigation and management of Wilson's disease: a practical guide from the British Association for the Study of the Liver.
The Lancet Gastroenterology and Hepatology
, 7
(6)
pp. 560-575.
10.1016/S2468-1253(22)00004-8.
|
Tai, D;
Dhar, A;
Yusuf, A;
Marshall, A;
O'Beirne, J;
Patch, D;
Tsochatzis, E;
... Westbrook, RH; + view all
(2018)
The Royal Free Hospital 'hub-and-spoke network model' delivers effective care and increased access to liver transplantation.
Public Health
, 154
pp. 164-171.
10.1016/j.puhe.2017.10.012.
|
Tan, L;
Perez, J;
Mela, M;
Miranda, E;
Burling, KA;
Rouhani, FN;
DeMeo, DL;
... Lomas, DA; + view all
(2015)
Characterising the association of latency with α(1)-antitrypsin polymerisation using a novel monoclonal antibody.
Int J Biochem Cell Biol
, 58
81 - 91.
10.1016/j.biocel.2014.11.005.
|
Valencia, Ana;
Vergara, Candelaria;
Thio, Chloe L;
Vince, Nicolas;
Douillard, Venceslas;
Grifoni, Alba;
Cox, Andrea L;
... Ignore, Continue; + view all
(2022)
Trans-ancestral fine-mapping of MHC reveals key amino acids associated with spontaneous clearance of hepatitis C in HLA-DQβ1.
American Journal of Human Genetics
, 109
(2)
pp. 299-310.
10.1016/j.ajhg.2022.01.001.
|
Vergara, C;
Duggal, P;
Thio, CL;
Valencia, A;
O' Brien, TR;
Latanich, R;
Timp, W;
... Taub, MA; + view all
(2020)
Multi-ancestry fine mapping of interferon lambda and the outcome of acute hepatitis C virus infection.
Genes and Immunity
, 21
(5)
pp. 348-359.
10.1038/s41435-020-00115-3.
|
Vergara, C;
Thio, CL;
Johnson, E;
Kral, AH;
O'Brien, TR;
Goedert, JJ;
Mangia, A;
... Duggal, P; + view all
(2019)
Multi-Ancestry Genome-Wide Association Study of Spontaneous Clearance of Hepatitis C Virus.
Gastroenterology
, 156
(5)
1496-1507.e7.
10.1053/j.gastro.2018.12.014.
|
Williams, R;
Alessi, C;
Alexander, G;
Allison, M;
Aspinall, R;
Batterham, RL;
Bhala, N;
... Yeoman, A; + view all
(2021)
New dimensions for hospital services and early detection of disease: a Review from the Lancet Commission into liver disease in the UK.
Lancet
, 397
(10286)
pp. 1770-1780.
10.1016/S0140-6736(20)32396-5.
|
Williams, R;
Aithal, G;
Alexander, GJ;
Allison, M;
Armstrong, I;
Aspinall, R;
Baker, A;
... Yeoman, A; + view all
(2020)
Unacceptable failures: the final report of the Lancet Commission into liver disease in the UK.
The Lancet
, 395
(10219)
pp. 226-239.
10.1016/S0140-6736(19)32908-3.
|
Williams, R;
Alexander, G;
Armstrong, I;
Baker, A;
Bhala, N;
Camps-Walsh, G;
Cramp, ME;
... Yeoman, A; + view all
(2018)
Disease burden and costs from excess alcohol consumption, obesity, and viral hepatitis: fourth report of the Lancet Standing Commission on Liver Disease in the UK.
The Lancet
, 391
(10125)
pp. 1097-1107.
10.1016/S0140-6736(17)32866-0.
|
Williams, R;
Alexander, G;
Aspinall, R;
Batterham, R;
Bhala, N;
Bosanquet, N;
Severi, K;
... Yeoman, A; + view all
(2018)
Gathering momentum for the way ahead: fifth report of the Lancet Standing Commission on Liver Disease in the UK.
The Lancet
, 392
(10162)
pp. 2398-2412.
10.1016/S0140-6736(18)32561-3.
|
Williams, R;
Alexander, G;
Aspinall, R;
Bosanquet, J;
Camps-Walsh, G;
Cramp, M;
Day, N;
... Yeoman, A; + view all
(2017)
New metrics for the Lancet Standing Commission on Liver Disease in the UK.
The Lancet
, 389
(10083)
pp. 2053-2080.
10.1016/S0140-6736(16)32234-6.
|